Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep disturbance and learning in children with BECCTS treated with sulthiame: randomized double-blind placebo-controlled cross-over trial
2011-001571-39Phase 4Terminated
- Sponsor
- University of Bristol
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sultiame in Benign Rolandic Epilepsy (BECTS) (2 arms), sponsored by University of Bristol. Primary endpoint: Frequency of interictal epileptiform discharges during slow wave sleep. Started Aug 2011; status: terminated.
02
Drugs
sultiame
03
Conditions
Benign Rolandic Epilepsy (BECTS)
Beyond the preview
Go deeper on 2011-001571-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001571-39.